This document provides best practice guidance for overlabelling of imported unlicensed
medicines and provision of translated leaflets in the UK. Its primary aim is to reduce the risk
of medication errors by ensuring essential information relating to the medicines is in English
and comprehensible to the healthcare professional.
This guidance will be of use to anyone purchasing, overlabelling or supplying imported
unlicensed medicines, and obtaining or providing translated leaflets.